Perspective : the evolution of R&D conduct in the pharmaceutical industry
Year of publication: |
2013
|
---|---|
Authors: | Schramm, Mary E. ; Hu, Michael Y. |
Published in: |
The journal of product innovation management : an international publication of the Product Development & Management Association. - Oxford : Blackwell Publishing, ISSN 0737-6782, ZDB-ID 722136-8. - Vol. 30.2013, S1, p. 203-213
|
Subject: | Arzneimittel | Pharmaceuticals | Wettbewerb | Competition | Markenführung | Brand management | Generika | Generic drugs | Produktlebenszyklus | Product life cycle | Innovationsmanagement | Innovation management | Produktmanagement | Product management | USA | United States |
-
Competition between generic and brand name drugs : new evidence from the U.S. pharmaceutical market
Cavaliere, Alberto, (2022)
-
Strategisches Pharma-Management : konsequente Wertoptimierung des Total-Life-Cycle
Dreger, Christian, (2000)
-
Granlund, David, (2012)
- More ...
-
An agent-based diffusion model with consumer and brand agents
Schramm, Mary E., (2010)
-
An agent-based diffusion model with consumer and brand agents
Schramm, Mary E., (2010)
-
Stock market response to strategic technical alliances between drug and biotechnology firms
Liu, Dandan, (2016)
- More ...